childhood
commun
acquir
pneumonia
continu
import
clinic
problem
individu
institut
commun
level
determin
microbi
etiolog
critic
develop
evidencebas
manag
therapeut
prophylact
decis
decad
approach
reli
cultur
lung
aspir
specimen
obtain
children
radiograph
confirm
pneumonia
administ
antibiot
studi
reveal
major
bacteria
associ
pneumonia
prompt
world
health
organ
develop
highli
sensit
clinic
definit
pneumonia
advoc
empir
antibiot
therapi
order
save
live
focus
commun
set
lack
resourc
diagnost
test
howev
spawn
research
studi
conduct
infrombi
institut
enrol
children
rel
nonspecif
definit
pneumonia
specif
got
compromis
abandon
lung
aspir
use
nasooro
pharyng
specimen
even
children
receiv
antibiot
led
recoveri
virus
often
bacteria
use
highli
sensit
molecular
base
diagnost
especi
pcr
facilit
detect
multipl
organ
bacteria
virus
atyp
organ
even
fungal
speci
make
difficult
attribut
etiolog
individu
case
challeng
sought
address
multisit
perch
studi
pneumonia
etiolog
research
child
health
design
casecontrol
studi
conclus
determin
etiolog
pneumonia
howev
despit
slew
public
answer
central
question
etiolog
emerg
far
sinc
none
perch
studi
site
locat
india
commun
acquir
pneumonia
etiolog
studi
cape
conduct
chandigarh
turn
largest
singlecentr
pneumonia
etiolog
studi
gener
wealth
data
articl
summar
current
challeng
pneumonia
etiolog
research
outlin
key
observ
perch
cape
project
well
import
studi
suggest
way
forward
pneumonia
etiolog
research
current
era
import
childhood
commun
acquir
pneumonia
cap
emphas
enough
continu
singl
import
caus
childhood
morbid
mortal
across
world
earli
nineti
annual
death
children
develop
countri
fifth
birthday
attribut
pneumonia
estim
respons
million
death
among
children
around
world
recent
worldwid
global
burden
diseas
gbd
analysi
suggest
cap
could
respons
approxim
million
childhood
death
translat
childhood
death
expect
global
burden
born
disproportion
resourceconstrain
countri
incid
childhood
cap
estim
fold
higher
resourc
rich
set
relat
higher
preval
baselin
risk
factor
malnutrit
inadequ
breast
feed
exposur
household
pollut
overcrowd
etc
natur
addit
risk
factor
exposur
hiv
set
compound
problem
addit
immens
public
heath
import
childhood
pneumonia
also
seriou
consequ
individu
child
besid
immedi
risk
complic
mortal
emerg
data
show
pneumonia
childhood
predispos
long
term
complic
decreas
lung
function
asthma
even
chronic
obstruct
lung
diseas
later
life
thu
determin
microbi
etiolog
childhood
pneumonia
consider
import
individu
level
impact
treatment
decis
whether
use
antibiot
choic
antibiot
durat
therapi
etc
institut
level
determin
antibiot
administr
polici
commun
level
decis
greater
implic
includ
pattern
antimicrobi
resist
public
health
perspect
appar
simpl
issu
govern
vaccin
andor
prophylaxi
polici
alloc
resourc
specif
programm
direct
extent
research
agenda
childhood
pneumonia
needless
mention
commerci
interest
antibiot
vaccin
deliveri
programm
etc
run
billion
dollar
almost
whole
centuri
direct
demonstr
organ
cultur
stain
method
lung
aspir
children
pneumonia
accept
approach
determin
microbi
etiolog
develop
develop
countri
includ
india
fact
lung
aspir
regard
gold
standard
determin
etiolog
approach
bolster
find
pulmonari
aspir
small
cohort
children
without
clinic
radiograph
pneumonia
uniformli
steril
suggest
lung
aspir
fals
posit
studi
focus
postmortem
lung
aspir
also
contribut
valuabl
data
main
premis
approach
lung
regard
steril
tissu
consequ
microorgan
found
regard
pathogen
lung
aspir
studi
demonstr
major
bacteria
implic
childhood
pneumonia
viz
streptococcu
pneumonia
haemophilu
influenza
along
staphylococcu
aureu
bacteria
studi
limit
number
studi
also
attempt
identifi
virus
either
cultur
method
immunofluoresc
emphas
mani
lung
aspir
analys
undertaken
children
radiograph
confirm
pneumonia
often
antibiot
administr
tabl
summar
data
exhaust
review
lung
aspir
studi
show
develop
countri
stop
perform
lung
aspir
time
develop
countri
start
studi
continu
till
midnineti
recent
studi
malawi
use
pcr
lung
aspir
sampl
children
radiograph
pneumonia
report
aspir
cultur
yield
bacteria
case
pcr
show
bacteria
case
virus
identifi
singli
combin
case
altogeth
lung
aspir
pcr
could
identifi
organ
children
anoth
small
studi
children
sever
pneumonia
underw
lung
aspir
pathogen
identifi
combin
cultur
pcr
lung
aspir
pleural
fluid
case
studi
examin
blood
surrog
sampl
howev
studi
compar
lung
aspir
blood
cultur
confirm
rel
poor
sensit
latter
review
seri
lung
aspir
could
identifi
organ
case
blood
cultur
could
identifi
etiolog
blood
cultur
neg
third
case
blood
lung
aspir
cultur
posit
less
onefifth
case
identif
bacteria
variou
studi
result
two
import
develop
widespread
ramif
first
led
global
effort
enhanc
use
antibiot
order
save
live
children
pneumonia
especi
resourc
limit
set
highli
sensit
clinic
definit
pneumonia
evolv
wherebi
field
worker
note
emphasi
resourc
constrain
set
could
identifi
treat
children
urgent
focu
prevent
mortal
definit
base
easi
recogn
clinic
symptom
sign
away
radiograph
confirm
global
expert
recogn
approach
could
ensur
child
fail
receiv
antibiot
would
result
overtreat
account
fals
posit
diagnosi
tradeoff
consid
accept
undesir
sideeffect
healthcar
system
develop
countri
access
resourc
facil
also
start
use
highli
sensit
definit
pneumonia
manag
individu
children
well
research
studi
spawn
seri
studi
pneumonia
etiolog
wherein
unknown
proport
enrol
children
probabl
actual
pneumonia
second
develop
enhanc
antibiot
usag
mani
studi
start
enrol
children
use
liber
definit
even
receiv
antibiot
vari
durat
time
natur
decreas
yield
bacteria
identifi
cultur
around
time
data
larg
multicentr
studi
site
develop
countri
acut
respiratori
tract
infect
ari
etiolog
becam
avail
studi
reli
blood
pleural
fluid
cultur
identifi
bacteria
nasopharyng
aspir
cultur
identifi
virus
studi
report
virus
especi
respiratori
syncyti
viru
identifi
often
bacteria
children
lower
respiratori
infect
enrol
commun
well
hospit
inpati
outpati
sens
open
floodgat
varieti
research
studi
examin
nasopharyng
swab
aspir
nasal
even
oropharyng
sampl
among
children
liber
definit
pneumonia
includ
prior
receipt
antibiot
nonspecif
sampl
vi
vi
lung
aspir
sampl
result
sever
bacteria
virus
identifi
accord
etiolog
statu
fact
trend
continu
till
ad
layer
advanc
molecular
techniqu
polymeras
chain
reaction
pcr
replac
cultur
faster
albeit
expens
method
pcr
highli
sensit
detect
microbi
footprint
although
less
specif
determin
causeandeffect
relationship
made
possibl
detect
multipl
organ
pathogen
otherwis
label
etiolog
agent
major
problem
approach
addit
nonspecif
definit
pneumonia
almost
bacteri
speci
implic
pneumonia
causat
pneumonia
h
influenza
aureu
mycoplasma
etc
also
found
nasopharynx
normal
children
get
colon
earli
life
without
suffer
infect
set
infer
detect
organ
impli
causal
akin
assum
anyon
detect
scene
crime
respons
problem
compound
studi
recent
year
show
virus
identifi
nasopharyng
secret
children
socal
pneumonia
also
identifi
upper
respiratori
infect
even
normal
ie
asymptomat
infant
children
recent
systemat
review
casecontrol
studi
suggest
detect
rsv
influenza
viru
human
metapneumoviru
parainfluenza
viru
nasopharyng
secret
case
associ
lower
respiratori
tract
infect
much
often
control
wherea
associ
virus
coronavirus
bocaviru
adenoviru
howev
entir
help
individu
children
except
trend
recent
public
zar
et
al
succinctli
outlin
rel
advantag
disadvantag
use
variou
biolog
specimen
blood
nasooro
pharyng
secret
blood
bronchoalveolar
lavag
lung
aspir
divers
method
identifi
organ
includ
cultur
pcr
antigen
detect
serolog
studi
etc
howev
singl
test
biolog
sampl
accur
establish
etiolog
children
pneumonia
tabl
summar
major
challeng
confirm
microbi
etiolog
childhood
pneumonia
pneumoniai
patholog
diagnosi
clinic
radiograph
correl
suggest
necessarili
confirm
presenc
howev
histopatholog
confirm
feasibl
individu
case
epidemiolog
studi
definit
compromis
either
sensit
exampl
radiograph
definit
andor
specif
exampl
definit
exampl
clinician
diagnos
pneumonia
definit
across
studi
difficulti
comparison
restrict
hospit
children
creat
bia
associ
healthseek
behavior
andor
strong
referr
system
andor
surviv
ie
children
die
reach
hospit
includ
use
radiograph
inclus
criteria
alway
use
standard
criteria
challeng
concept
modern
time
highli
unlik
koch
postul
determin
etiolog
fulfil
research
studi
assumpt
identif
organ
indic
causal
even
lung
aspir
andor
blood
sampl
necessarili
correct
challeng
biolog
specimen
determin
etiolog
ideal
specimen
would
lung
tissu
area
pneumonia
note
emphasi
obtain
onset
ill
feasibl
routin
clinic
practic
research
studi
closest
ideal
radiograph
guid
lung
aspir
biopsi
bronchoalveolar
lavag
onset
ill
least
present
difficult
ethic
technic
andor
epidemiolog
reason
aspiratesbiopsi
bronchoalveolar
lavag
specimen
later
cours
diseas
death
hospit
children
creat
risk
detect
hospit
acquir
pathogen
especi
sick
children
multipl
intervent
includ
intub
lung
necessarili
steril
tissu
dynam
microbiom
could
influenc
varieti
factor
aspir
also
foolproof
neg
result
observ
despit
target
correct
area
obtain
appropri
repres
sampl
cours
risk
associ
techniqu
although
regard
safe
expert
hand
limit
sensit
possibl
specif
childhood
pneumonia
swab
nasopharyng
aspir
nasopharyng
swab
oropharyng
swab
necessarili
reflect
organ
lower
airway
lung
often
produc
infant
young
children
sputum
viabl
altern
requir
premed
bronchodil
risk
induc
emesi
aspir
andor
lavag
sampl
use
detect
organ
resist
gastric
acid
volum
blood
use
cultur
alter
result
ideal
volum
blood
requir
may
obtain
young
infant
children
prior
antibiot
rampant
set
uncontrol
access
compromis
find
blood
extent
lung
aspir
biomark
correl
microbi
etiolog
challeng
process
biolog
specimen
determin
etiolog
need
collect
transport
lab
process
appropri
although
sampl
collect
often
time
delay
transport
andor
process
usual
gold
standard
bacteria
limit
sensit
organ
pcr
molecular
base
method
higher
sensit
difficult
distinguish
live
organ
dead
organ
remnant
organ
method
detect
organ
pcr
gener
report
posit
neg
howev
depend
limit
detect
gener
report
detect
organ
look
word
inher
select
bia
result
miss
organ
search
andor
novelunexpect
organ
design
identifi
one
limit
number
select
microorgan
inher
bias
sensit
method
often
reveal
footprint
multipl
organ
contributori
role
etiolog
unclear
base
test
atyp
organ
unreli
determin
etiolog
antigen
urin
lack
specif
detect
one
organ
variou
biolog
specimen
need
mean
causal
signific
interpret
differ
organ
differ
biolog
specimen
individu
case
unclear
control
studi
suggest
pathogen
overal
group
confirm
individu
case
whole
group
control
studi
factor
data
multipl
specimen
invasivepain
method
gener
use
control
unclear
children
healthi
non
pneumonia
respiratori
infect
serv
control
casecontrol
studi
method
latent
class
analysi
slot
case
etiolog
class
confirm
etiolog
individu
case
recogn
problem
bill
melinda
gate
foundat
initi
multicentr
perch
pneumonia
etiolog
research
child
health
studi
seven
develop
countri
contribut
nine
site
confirm
microbi
etiolog
childhood
pneumonia
design
casecontrol
studi
among
less
exclud
neonat
identifi
pathogen
multipl
biolog
sampl
viz
blood
naso
oro
pharyng
swab
induc
sputum
case
multipl
method
viz
cultur
pcr
case
hospit
defin
sever
pneumonia
control
agefrequ
match
children
healthi
well
nonpneumonia
respiratori
symptom
numer
methodolog
refin
introduc
enhanc
valid
studi
includ
effort
standard
definit
clinic
method
sampl
collect
laboratori
method
chest
radiographi
perform
interpret
addit
refin
includ
document
studi
effect
prior
antibiot
therapi
also
volum
blood
drawn
bacteri
cultur
result
relationship
bacteri
densiti
upper
airway
blood
cultur
correl
viral
load
upper
airway
pneumonia
addit
tremend
emphasi
given
appropri
data
manag
qualiti
control
data
analysi
interpret
resourc
intens
term
time
manpow
materi
effort
foster
assur
high
intern
extern
valid
result
summari
main
result
report
till
date
shown
tabl
howev
far
perch
studi
report
central
question
pneumonia
etiolog
none
perch
site
locat
india
howev
india
reportedli
contribut
largest
number
childhood
pneumonia
case
greatest
mortal
childhood
death
underf
age
group
india
tremend
global
pressur
initi
administr
pneumococc
conjug
vaccin
pcv
routin
immun
programm
although
scientif
rational
evid
base
controversi
despit
none
numer
indian
studi
childhood
pneumonia
etiolog
design
address
challeng
present
tabl
therefor
commun
acquir
pneumonia
etiolog
studi
cape
initi
pgimer
chandigarh
collabor
karolinska
institut
stockholm
studi
enrol
children
mo
pneumonia
imnci
criteria
identifi
activ
surveil
commun
passiv
surveil
hospit
outpati
depart
well
emerg
period
april
decemb
overal
approxim
children
screen
enrol
make
one
world
largest
singlecentr
studi
pneumonia
etiolog
children
receiv
antibiot
h
present
exclud
laboratori
test
includ
blood
nasopharyng
aspir
npa
bacteri
cultur
serolog
duplic
mycoplasma
pneumonia
chlamydophila
pneumonia
multiplex
pcr
bacterialvir
speci
undertaken
subgroup
select
repres
entir
cohort
addit
children
requir
endotrach
intub
bronchoalveolar
lavag
bal
specimen
taken
cultur
multiplex
pcr
thu
comprehens
studi
design
determin
microbi
etiolog
salient
result
conclus
strength
limit
avail
data
publish
far
briefli
present
tabl
challeng
distinguish
nasopharyng
colon
organ
pneumonia
caus
pathogen
plagu
pneumonia
etiolog
research
worldwid
order
better
understand
time
pattern
nasopharyng
colon
indian
infant
longitudin
studi
initi
pgimer
chandigarh
cohort
infant
enrol
birth
nasopharyng
aspir
sampl
obtain
infant
serial
follow
till
age
visit
coincid
vaccin
visit
histori
respiratori
tract
infect
person
famili
member
preced
two
week
obtain
free
symptom
sign
preced
underw
nasopharyng
aspir
analysi
bacteri
cultur
viral
multiplex
pcr
data
analys
preliminari
result
suggest
earli
colon
case
birth
wide
array
bacteria
virus
dynam
pattern
organ
relationship
recent
ie
upper
respiratori
tract
infect
infant
famili
member
suggest
dynam
microbiom
could
impact
microbi
etiolog
event
lower
respiratori
tract
infect
order
address
limit
cape
smaller
prospect
studi
cape
undertaken
pgimer
chandigarh
wherein
children
sever
pneumonia
receiv
prior
antibiot
enrol
addit
blood
nasopharyng
aspir
sampl
sputum
induc
sputum
applic
pleural
fluid
sampl
obtain
children
nonresolut
symptom
within
h
bronchoalveolar
lavag
lung
aspir
specimen
obtain
postmortem
lung
aspir
also
drawn
sampl
process
bacteri
cultur
viral
analysi
multiplex
pcr
organ
addit
select
serolog
test
atyp
organ
preliminari
analysi
provid
rich
pool
data
blood
nasopharyng
aspir
cultur
posit
case
respect
compar
cape
confirm
advers
impact
even
h
antibiot
intak
prior
present
bal
cultur
posit
one
third
specimen
acinetobact
domin
rais
dilemma
whether
acquir
hospit
lung
aspir
obtain
nonrespons
children
gave
poor
yield
bacteria
cultur
sever
virus
could
identifi
pcr
expect
plethora
virus
identifi
pcr
nasopharyng
aspir
problem
attribut
etiolog
encount
addit
analysi
data
cohort
underway
indian
council
medic
research
icmr
took
cogniz
import
pneumonia
etiolog
india
ongo
cape
project
decid
initi
multicentr
studi
across
india
confirm
microbi
etiolog
five
institut
select
cmc
vellor
pgimer
chandigarh
kgmu
lucknow
kem
pune
nice
kolkata
contribut
case
commun
hospit
base
control
detail
project
protocol
prepar
emphasi
case
definit
clinic
protocol
sampl
scheme
case
control
laboratori
test
includ
cultur
pcr
advanc
molecular
techniqu
fund
recent
secur
studi
expect
initi
late
find
cape
studi
clearli
suggest
wide
variat
clinic
present
cours
outcom
children
pneumonia
even
enrol
case
control
nine
site
seven
develop
countri
control
includ
healthi
children
well
respiratori
symptom
fulfil
definit
pneumonia
bioassay
confirm
prior
antibiot
use
case
control
evalu
combin
assess
histori
referr
document
bioassay
identifi
prior
antibiot
use
case
antibiot
exposur
reduc
probabl
detect
bacteria
cultur
pcr
although
effect
aureu
unclear
volum
blood
obtain
cultur
show
direct
relationship
isol
bacteria
highest
yield
ml
taken
effect
consist
children
without
prior
receipt
antibiot
pneumonia
identifi
cultur
blood
pleural
fluid
lung
aspir
case
howev
none
site
asia
singl
cultureproven
case
despit
absenc
pneumococc
vaccin
programm
pneumonia
pcr
blood
posit
case
also
control
howev
case
cultur
confirm
pneumococc
bacteremia
pcr
posit
fact
children
without
confirm
bacteri
infect
also
pcr
posit
data
suggest
blood
pcr
may
suitabl
test
pneumococc
pneumonia
pcr
pneumococcu
nasooro
pharyng
sampl
show
significantli
higher
load
case
cultureproven
pneumococcu
n
compar
case
without
pneumococcu
well
control
howev
cutoff
valu
copiesml
distinguish
confirm
pneumococc
case
vs
control
sensit
specif
quantit
load
pneumococcu
determin
pcr
higher
cultur
posit
case
control
signific
overlap
preclud
accur
differenti
confirm
limit
util
quantit
pneumococc
pcr
blood
diagnos
pneumococc
pneumonia
microbiolog
confirm
case
follow
organ
h
influenza
catarrhali
aureu
p
jirovecii
asian
site
quantit
pcr
nasooro
pharyng
sampl
could
reliabl
distinguish
cultur
confirm
case
vs
control
case
control
least
one
virus
test
multiplex
pcr
nasopharyngealoropharyng
sampl
respect
proport
virus
virus
estim
viral
load
nasopharyngealoropharyng
sampl
show
consider
overlap
radiograph
confirm
case
control
children
sever
pneumonia
die
higher
viral
load
find
suggest
quantit
pcr
virus
may
discriminatori
yield
bacteria
virus
pcr
induc
sputum
sampl
compar
obtain
pcr
nasooropharyng
specimen
quantit
analysi
provid
addit
inform
pertussi
detect
case
control
nasooro
pharyng
aspir
suggest
possibl
role
pneumonia
disproportion
high
mortal
among
case
hundr
thirti
five
interpret
chest
radiograph
show
abnorm
although
consolid
seen
far
fewer
children
signific
variat
across
site
classic
clinic
sign
sever
pneumonia
hypoxemia
fever
tachypnea
etc
observ
frequent
radiograph
abnorm
mgl
observ
hivneg
case
bacteri
pneumonia
defin
posit
blood
cultur
posit
lung
aspir
pleural
fluid
cultur
pcr
compar
rsv
pneumonia
case
defin
nasopharyngealoropharyng
induc
sputum
pcrposit
without
confirmedsuspect
bacteri
pneumonia
suggest
util
distinguish
bacteri
vs
rsvassoci
pneumonia
although
virus
howev
children
bacteria
rsv
also
crp
mgl
wide
variat
result
obtain
site
signific
differ
site
asia
compar
africa
develop
biorepositori
specimen
later
test
limit
set
organ
identifi
divers
specimen
use
variou
process
method
rais
question
whether
microb
alon
singli
combin
held
respons
pneumonia
cours
well
known
environment
factor
nutrit
statu
live
condit
gestat
age
breastfeed
pattern
etc
influenc
occurr
cours
outcom
pneumonia
individu
case
commun
howev
also
possibl
host
respons
colon
andor
infect
could
account
individu
variat
cours
outcom
repres
subgroup
cape
cohort
abl
evalu
panel
cytokin
chemokin
common
organ
isol
blood
staphyococcu
aureu
streptococcu
pneumonia
neg
bacilli
klebsiella
pneumonia
acinetobact
speci
salmonella
typhi
togeth
outnumb
pneumococc
isol
lavag
cultur
done
limit
number
case
present
identifi
organ
pcr
bal
yield
organ
sampl
howev
singl
organ
bacteria
viru
found
rest
multipl
organ
differ
combin
aspir
cultur
posit
case
pneumonia
predomin
follow
h
influenza
aureu
pcr
nasopharyng
aspir
sampl
yield
multipl
bacteria
virus
children
show
speci
look
major
multipl
organ
make
imposs
attribut
causal
singl
bacteri
speci
observ
case
singl
viru
identifi
case
cytomegaloviru
cmv
domin
isol
among
virus
follow
rsv
follow
rhinoviru
coronaviru
parainfluenza
viru
influenza
viru
etc
yield
bacteria
pcr
nasopharyng
aspir
sever
fold
higher
cultur
vs
pneumonia
vs
h
influenza
vs
aureu
pattern
distribut
organ
class
similar
children
nonsever
sever
sever
pneumonia
distribut
organ
children
die
significantli
differ
survivor
test
done
duplic
pneumonia
c
pneumonia
posit
respect
among
case
singl
bacteri
viral
isol
analysi
variou
factor
show
imposs
predict
bacteri
vs
viral
etiolog
present
salient
conclus
sampl
inappropri
specimen
determin
pneumonia
etiolog
presenc
multipl
organ
major
bronchoalveolar
lavag
specimen
albeit
taken
cours
ill
rather
present
preclud
attribut
etiolog
case
difficult
determin
whether
detect
multipl
potenti
pathogen
repres
true
mix
infect
whether
infect
one
organ
encourag
harmless
colon
becom
pathogen
cultur
poor
sensit
pneumonia
etiolog
staphylococcu
aureu
gram
neg
rod
neither
target
current
vaccin
import
pathogen
salient
strength
singlecentr
studi
childhood
pneumonia
etiolog
commun
hospit
case
case
definit
pneumonia
pneumonia
sever
report
protocol
chest
radiographi
process
test
done
accredit
laboratori
india
test
done
confirm
antibiot
activ
serum
henc
result
could
separ
analyz
children
without
prior
antibiot
therapi
pcr
could
undertaken
subgroup
children
repres
whole
cohort
account
financi
constraint
bacteria
especi
pneumonia
could
undertaken
due
financi
constraint
lavag
perform
present
accord
institut
protocol
intub
children
creat
risk
detect
hospit
acquir
colonizationinfect
aspir
perform
test
qualit
quantit
although
limit
detect
organ
prespecifi
result
chest
radiograph
find
pend
aim
identifi
signatur
could
serv
potenti
biomark
pneumonia
sever
probabl
largest
panel
potenti
biomark
studi
singl
cohort
signific
differ
level
chemokin
children
sever
vs
nonsever
pneumonia
time
present
likewis
children
die
show
signific
differ
survivor
level
four
chemokin
howev
none
could
act
reliabl
biomark
predict
either
sever
outcom
plan
addit
studi
fund
avail
past
decad
pneumonia
etiolog
research
wit
shift
studi
focus
specif
term
definit
pneumonia
usual
radiolog
evid
specimen
collect
gener
lung
aspir
antibiot
children
process
cultur
bacteria
virus
current
focu
sensit
evidenc
liber
clinic
definit
pneumonia
surrog
specimen
presenc
prior
antibiot
use
molecular
method
therebi
compromis
specif
thrown
lot
data
key
issu
pinpoint
etiolog
individu
case
still
elus
paradox
statement
made
ago
ba
wide
varieti
virus
associ
respiratori
tract
infect
specif
etiolog
agent
found
signific
proport
patient
appear
true
even
today
entir
differ
reason
consid
kind
pneumonia
etiolog
studi
undertaken
data
avail
far
suggest
new
pneumonia
etiolog
studi
attempt
rectifi
rather
replic
limit
describ
expert
shann
insist
etiolog
childhood
pneumonia
confirm
lung
aspir
analysi
children
antibiot
howev
person
experi
confirm
easi
convinc
research
colleagu
ethic
board
fund
agenc
children
famili
lung
aspir
given
small
definit
risk
event
pneumothorax
necessit
enhanc
monitor
situat
bronchoscop
bronchoalveolar
lavag
specimen
obtain
present
hospit
children
could
ideal
materi
bronchoscopi
advantag
target
specif
area
lung
identifi
digit
radiographi
hand
experienc
clinician
safe
procedur
yield
wealth
data
pathogen
identif
also
host
respons
analysi
bal
cytolog
cytokin
chemokin
fraction
laboratori
process
continu
use
tradit
method
especi
bacteri
cultur
addit
modern
techniqu
natur
reason
larg
sampl
size
case
would
requir
make
research
studi
timeconsum
expens
hand
argu
wealth
data
avail
excel
studi
across
globe
make
clear
determin
microbi
etiolog
individu
case
pneumonia
complex
perhap
imposs
task
even
resourceintens
perch
studi
far
abl
address
issu
despit
complex
statist
wizardri
appear
best
identifi
pattern
organ
distribut
commun
epidemiolog
heterogen
mani
respect
therefor
doubt
whole
countri
even
region
within
countri
behav
singl
epidemiolog
unit
like
wide
variat
even
within
defin
geograph
polit
boundari
backdrop
pertin
wonder
whether
realli
need
invest
time
money
manpow
resourc
know
precis
microbi
etiolog
individu
pneumonia
case
routin
basi
would
enough
could
predict
reason
well
likelihood
bacteri
vs
viral
atyp
infect
infect
without
actual
identifi
organ
case
except
tuberculosi
identifi
factor
predict
advers
outcom
complic
nonrespons
therapi
mortal
deeper
level
microorgan
pathogen
potenti
creat
diseas
vari
sever
children
leav
other
unaffect
word
emphasi
pneumonia
etiolog
research
shift
effort
mere
identifi
pathogen
holist
approach
embrac
epidemiolog
triad
compris
agent
factor
ie
caus
organ
becom
pathogen
individu
children
host
factor
macro
level
put
risk
factor
well
micro
level
individu
immuneinflammatori
respons
environment
factor
macro
micro
level
complex
interplay
among
conflict
interest
none
sourc
fund
none
